Chimeric autoantibody receptor cell therapy for the treatment of membranous nephropathy: The authors reply
Standard
Chimeric autoantibody receptor cell therapy for the treatment of membranous nephropathy: The authors reply. / Fehse, Boris; Tomas, Nicola M.
in: KIDNEY INT, Jahrgang 105, Nr. 6, 06.2024, S. 1320-1321.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Letter › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Chimeric autoantibody receptor cell therapy for the treatment of membranous nephropathy: The authors reply
AU - Fehse, Boris
AU - Tomas, Nicola M
PY - 2024/6
Y1 - 2024/6
KW - Humans
U2 - 10.1016/j.kint.2024.03.006
DO - 10.1016/j.kint.2024.03.006
M3 - Letter
C2 - 38777406
VL - 105
SP - 1320
EP - 1321
JO - KIDNEY INT
JF - KIDNEY INT
SN - 0085-2538
IS - 6
ER -